美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MapLight Therapeutics, Inc.

18.20

+0.63003.59%

成交量：5.90萬

成交額：105.81萬

市值：8.26億

市盈率：-8.03

高：18.29

開：17.49

低：17.04

收：17.57

52周最高：21.55

52周最低：12.24

股本：4,537.30萬

流通股本：1,522.67萬

量比：0.96

換手率：0.39%

股息：- -

股息率：- -

每股收益(TTM):-2.2660

每股收益(LYR):-105.3781

淨資產收益率：--

總資產收益率：--

市淨率：-3.01

市盈率(LYR):-0.17

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Maplight Therapeutics, Inc.盤中異動快速上漲5.06%

MapLight Therapeutics阿爾茨海默病精神病藥物ML-007C-MA獲FDA快速通道認定

Aktis Oncology申請美國IPO，生物技術公司上市反彈

MapLight獲得合作化合物臨牀開發和商業化的獨家權利

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MPLT"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MPLT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":18.2,"timestamp":1770741578147,"preClose":17.57,"halted":0,"volume":59030,"delay":0,"changeRate":0.03585657370517922,"floatShares":15226707,"shares":45373000,"eps":-2.266,"marketStatus":"交易中","change":0.63,"latestTime":"02-10 11:39:43 EST","open":17.49,"high":18.29,"low":17.035,"amount":1058123.0802499999,"amplitude":0.071429,"askPrice":18.27,"askSize":208,"bidPrice":18.19,"bidSize":316,"shortable":3,"etf":0,"ttmEps":-2.266,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":17.57,"postHourTrading":{"tag":"盘后","latestPrice":17.57,"preClose":17.57,"latestTime":"16:49 EST","volume":818,"amount":14372.26,"timestamp":1770673798922,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.95817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","floatShares":15226707,"roa":"--","roe":"--","lyrEps":-105.378114,"volumeRatio":0.95817,"shares":45373000,"dividePrice":0,"high":18.29,"amplitude":0.071429,"preClose":17.57,"low":17.035,"week52Low":12.24,"pbRate":"-3.01","week52High":21.55,"institutionHeld":0,"latestPrice":18.2,"committee":0.206107,"eps":-2.266,"divideRate":0,"volume":59030,"delay":0,"ttmEps":-2.266,"open":17.49,"prevYearClose":17.565,"prevWeekClose":16.98,"prevMonthClose":17.69,"prevQuarterClose":17.565,"fiveDayClose":17.11,"twentyDayClose":19.07,"sixtyDayClose":14.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MPLT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MPLT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MPLT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1763960400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MPLT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MPLT","date":"2026-02-09","current":-7.753751,"percent":0.71831,"low":-8.946167,"twenty":-7.997597,"median":-7.581919,"eighty":-6.918981,"high":-6.048324,"avg":-7.503977,"sd":0.680487,"marketCap":741031345},"quantilePoints":[{"date":"2025-10-31","current":-8.673514,"twenty":-8.310978,"median":-7.61973,"eighty":-7.489746,"marketCap":801692922},{"date":"2025-11-07","current":-7.620605,"twenty":-8.035178,"median":-7.644213,"eighty":-7.545137,"marketCap":704372551},{"date":"2025-11-14","current":-6.742394,"twenty":-7.98511,"median":-7.554503,"eighty":-7.23627,"marketCap":623199506},{"date":"2025-11-21","current":-6.274959,"twenty":-7.73109,"median":-7.394197,"eighty":-6.810384,"marketCap":579994498},{"date":"2025-11-28","current":-6.435493,"twenty":-7.639491,"median":-7.190943,"eighty":-6.54881,"marketCap":594832581},{"date":"2025-12-05","current":-7.783335,"twenty":-7.714027,"median":-7.115398,"eighty":-6.435493,"marketCap":800383679},{"date":"2025-12-12","current":-8.528142,"twenty":-7.986054,"median":-7.394197,"eighty":-6.45249,"marketCap":876974375},{"date":"2025-12-19","current":-8.462361,"twenty":-8.266224,"median":-7.554503,"eighty":-6.54881,"marketCap":870209954},{"date":"2025-12-26","current":-7.689969,"twenty":-8.289163,"median":-7.620605,"eighty":-6.624355,"marketCap":790782566},{"date":"2026-01-02","current":-7.454432,"twenty":-8.20424,"median":-7.61973,"eighty":-6.670627,"marketCap":766561577},{"date":"2026-01-09","current":-7.295285,"twenty":-8.111814,"median":-7.53948,"eighty":-6.75706,"marketCap":750196044},{"date":"2026-01-16","current":-7.84275,"twenty":-8.074467,"median":-7.609335,"eighty":-6.818055,"marketCap":806493478},{"date":"2026-01-23","current":-7.885189,"twenty":-7.999774,"median":-7.554503,"eighty":-6.827382,"marketCap":810857620},{"date":"2026-01-30","current":-7.885189,"twenty":-8.004018,"median":-7.620167,"eighty":-6.893484,"marketCap":810857620},{"date":"2026-02-06","current":-6.662942,"twenty":-7.999774,"median":-7.609335,"eighty":-6.893484,"marketCap":685170325},{"date":"2026-02-09","current":-7.206163,"twenty":-7.997597,"median":-7.581919,"eighty":-6.918981,"marketCap":741031345}],"updateTime":1770719296711},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MPLT\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606739773","title":"Maplight Therapeutics, Inc.盤中異動 快速上漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606739773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606739773?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 00:41","pubTimestamp":1769532107,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日00时41分，Maplight Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报18.89美元/股，成交量7.608万股，换手率0.17%，振幅6.34%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Biomx Inc.、Briacell Therapeutics Corp C/Wts 、Lisata Therapeutics, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为2036.13%、748.47%、230.41%，振幅较大的相关个股有Biomx Inc.、Vyome Holdings, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为53.90%、39.87%、37.46%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128004148953e9a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128004148953e9a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MPLT","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"1167154321","title":"MapLight Therapeutics阿爾茨海默病精神病藥物ML-007C-MA獲FDA快速通道認定","url":"https://stock-news.laohu8.com/highlight/detail?id=1167154321","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167154321?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 20:02","pubTimestamp":1767614544,"startTime":"0","endTime":"0","summary":"生物制药公司MapLight Therapeutics宣布，其针对阿尔茨海默病精神病症状的候选药物ML-007C-MA已获得美国食品药品监督管理局（FDA）授予的快速通道资格。这一认定将加速该药物的临床开发与审评进程，为患者提供更早获得创新疗法的可能。\nML-007C-MA是一种针对特定神经机制的新型治疗药物，旨在缓解阿尔茨海默病患者常见的精神病性症状，如幻觉、妄想和激越行为。快速通道资格的获得，意味着FDA认可该药物在未满足医疗需求领域的潜在价值，并将通过更频繁的沟通、滚动审评等机制支持其研发。\n公司表示将积极推进后续临床试验，力争早日为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"gpt_icon":0},{"id":"2592118027","title":"Aktis Oncology申請美國IPO，生物技術公司上市反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118027","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118027?lang=zh_tw&edition=fundamental","pubTime":"2025-12-20 06:45","pubTimestamp":1766184351,"startTime":"0","endTime":"0","summary":"Aktis Oncology申请美国IPO，生物技术公司上市反弹路透12月19日 - Aktis Oncology公司周五在美国提交了首次公开募股申请，生物技术行业的股市上市在经历了放缓后出现反弹。Aktis Oncology 公司由生物技术投资者托德-福里于 2020 年 8 月共同创立，目前正在开发治疗多种实体瘤的药物。Aktis Oncology 的主要候选药物 AKY-1189 正在进行早期研究，以治疗某些实体瘤，包括一种晚期膀胱癌、乳腺癌和结直肠癌。Aktis Oncology 公司的前身是 HotKnot Therapeutics 公司，将在纳斯达克上市，股票代码为 \"AKTS\"。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL4T3XP1JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791807156.HKD","LU1363072403.SGD","LU0203347892.USD","LU2129689431.USD","LU0648000940.SGD","LU2129689514.USD","MPLT","LU0256863811.USD","IE00B7SZLL34.SGD","BAC","LU0477156797.USD","LBRX","LU1035773651.USD","LU0306807586.USD","LU1069347547.HKD","LU0310800965.SGD","LU0980610538.SGD","LU0234572021.USD","LU1883839398.USD","LU1162221912.USD","LU1804176565.USD","IE0034235188.USD","BK4534","LU0130102774.USD","LU0130517989.USD","MNSH","LU1894683348.USD","LU1201861165.SGD","IE00BLSP4452.SGD","LU1074936037.SGD","IE00BBT3K403.USD","IE00BZ1G4Q59.USD","IE0001KFT4U8.USD","BK4585","LU0648001328.SGD","LU0052756011.USD","LU0128525689.USD","EVMN","LU0306806265.USD","BK4553","LU1201861249.SGD","LU0320765489.SGD","LU0130103400.USD","OWL","LU1668664300.SGD","LU0208291251.USD","LU0321505439.SGD","LU0256863902.USD","LU1880398554.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"1119775214","title":"MapLight獲得合作化合物臨牀開發和商業化的獨家權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1119775214","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119775214?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 20:06","pubTimestamp":1765886772,"startTime":"0","endTime":"0","summary":"MapLight获得合作化合物临床开发和商业化的独家权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MPLT\",params:#limit:6,delay:false,,,undefined,":[]}}